TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 25 of 283 • 7,055 articles
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit
GlobeNewswire Inc. • Zymeworks Inc.
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit

01/06/2026 01:34 PM • Zymeworks announced positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in combination with chemotherapy, with or without tislelizumab, for first-line treatment of HER2-positive gastroesophageal adenocarcinoma. The trial demonstrated statistically significant improvements in progression-free survival (approximately 35% risk reduction) and overall survival (26.4 months median, representing a 7+ month improvement over trastuzumab). Zymeworks is eligible to receive up to $440 million in milestone payments from regulatory approvals across major markets.

JEF - Mentioned as a conference host with no specific positive or negative implications
ZYME - Positive Phase 3 trial results demonstrating significant clinical benefits (7+ month OS improvement, longest reported in GEA Phase 3 trials), potential to become new standard of care, and substantial near-term milestone payments ($440M) from partners Jazz and BeOne across major markets (US, Europe, Japan, China). Results validate the company's Azymetric platform technology.
#HER2-positive gastroesophageal cancer #zanidatamab #Phase 3 trial #overall survival benefit #first-line treatment #immunotherapy combination #Azymetric platform #regulatory milestones
Read More
Global Sleep Tech Devices Market Poised for Strong Growth at a CAGR of ~17% by 2032, Driven by Rising Sleep Disorder Prevalence | DelveInsight
GlobeNewswire Inc. • Delveinsight
Global Sleep Tech Devices Market Poised for Strong Growth at a CAGR of ~17% by 2032, Driven by Rising Sleep Disorder Prevalence | DelveInsight

01/06/2026 01:00 PM • The global sleep tech devices market is expected to grow from USD 17 billion in 2024 to USD 44 billion by 2032, driven by rising sleep disorder prevalence, increased awareness, and technological advancements. Wearables dominate with 69.69% revenue share, while North America leads regional growth. Key players include Philips, ResMed, Apple, Garmin, and Eight Sleep.

RMD - Identified as a key player in the sleep tech market, which is experiencing strong growth driven by increasing adoption of home-based care and remote patient monitoring solutions.
#sleep tech devices #wearables #sleep disorders #market growth #CAGR 17% #insomnia #obstructive sleep apnea #remote patient monitoring #AI integration #smartwatches
Read More
Nombre d'actions et de droits de vote au 31 décembre 2025
GlobeNewswire Inc. • Na
Nombre d'actions et de droits de vote au 31 décembre 2025

01/06/2026 01:00 PM • Orange has signed a binding agreement with Lorca to acquire their 50% stake in MasOrange, consolidating full ownership of the joint venture. The announcement was made on December 12, 2025.

ORANY - The acquisition of Lorca's 50% stake in MasOrange represents strategic consolidation and increased control over the joint venture, which is typically viewed as a positive development for shareholder value and operational control.
#acquisition #MasOrange #joint venture #binding agreement #stake purchase
Read More
Total number of shares and voting rights at December 31, 2025
GlobeNewswire Inc. • Na
Total number of shares and voting rights at December 31, 2025

01/06/2026 01:00 PM • Orange has signed a binding agreement with Lorca to acquire their 50% stake in MasOrange, consolidating full ownership of the joint venture. The announcement was made on December 12, 2025.

AREBW - Company is expanding distribution, meeting with numerous distributors, and successfully entering new markets with strategic partnerships
ORANY - The acquisition of Lorca's 50% stake in MasOrange represents strategic consolidation and increased control over the joint venture, which is typically viewed as a positive development for shareholder value and operational control.
#acquisition #MasOrange #joint venture #stake purchase #binding agreement
Read More
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTF
GlobeNewswire Inc. • Juan Monteverde
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTF

01/06/2026 12:56 PM • Class action law firm Monteverde & Associates PC is investigating four merger and acquisition transactions: Dynavax Technologies' sale to Sanofi ($15.50/share), FONAR Corporation's sale to affiliates of its CEO ($19.00-$6.34/share), DigitalBridge Group's sale to SoftBank ($16.00/share), and ON24's sale to Cvent Atlanta ($8.10/share). The firm is seeking shareholders to determine if the proposed deal terms are fair.

KMB - Mentioned as an offtake agreement partner for green hydrogen, indicating potential sustainability initiatives
DVAX - Under investigation by class action firm regarding sale to Sanofi, suggesting potential concerns about deal fairness or shareholder value
#class action #merger investigation #shareholder rights #M&A transaction #deal fairness
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
GlobeNewswire Inc. • Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT

01/06/2026 12:53 PM • Pomerantz LLP is investigating potential securities fraud claims against Corcept Therapeutics following the FDA's issuance of a Complete Response Letter for its relacorilant drug on December 31, 2025. Despite the company's pivotal GRACE trial meeting its primary endpoint, the FDA requested additional effectiveness evidence. The announcement triggered a 50.42% stock price decline, falling from $70.20 to $34.80 per share.

CORT - The company received an FDA Complete Response Letter denying approval for its lead drug candidate relacorilant, resulting in a severe 50.42% stock price decline. Additionally, securities fraud investigations have been initiated against the company and its officers/directors, indicating potential investor harm and regulatory setbacks.
#securities fraud #class action lawsuit #FDA Complete Response Letter #relacorilant #hypercortisolism #stock price decline #drug approval
Read More
The 2026 Washington, D.C. Auto Show Welcomes New Manufacturers, Returning Favorites, and Immersive Experiences
GlobeNewswire Inc. • Na
The 2026 Washington, D.C. Auto Show Welcomes New Manufacturers, Returning Favorites, and Immersive Experiences

01/06/2026 12:53 PM • The 2026 Washington, D.C. Auto Show returns to the Walter E. Washington Convention Center from January 23 to February 1, 2026, featuring new manufacturers like Harley-Davidson and VinFast alongside returning brands such as Land Rover. Major automakers including Kia, Chevrolet, Toyota, Tesla, Polestar, and Subaru will showcase their latest vehicles, with highlights including Kia's Telluride Hybrid Prototype and Polestar's electric lineup. The show will feature exclusive Ride & Drive experiences and interactive exhibits celebrating automotive innovation and sustainability.

HOG - New manufacturer entry to the show expands their market presence and visibility to D.C. automotive enthusiasts, representing growth opportunity.
#auto show #electric vehicles #automotive innovation #Ride & Drive experiences #sustainable transportation #new manufacturers #vehicle showcase
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Era Energy & Digital, Inc. - NUAI
GlobeNewswire Inc. • Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Era Energy & Digital, Inc. - NUAI

01/06/2026 12:51 PM • Pomerantz LLP is investigating New Era Energy & Digital (NUAI) for potential securities fraud following damaging reports from short-sellers Fuzzy Panda and Hunterbrook. Fuzzy Panda alleged the company spent 2.5x more on stock promotions than operations, while Hunterbrook reported New Mexico sued the company for orchestrating a fraudulent oil-and-gas scheme. NUAI stock fell 6.9% on December 13 and another 48.03% by December 29, 2025.

NUAI - Company faces multiple serious allegations including securities fraud investigation, short-seller reports questioning business practices and CEO history, state lawsuit for fraudulent oil-and-gas scheme, and significant stock price declines (55% total over two weeks). Multiple credibility challenges and regulatory/legal issues indicate substantial investor risk.
#securities fraud #class action lawsuit #short seller report #stock price decline #oil and gas #penny stock #environmental liability
Read More
EVP and COO Sells 23,654 Innodata Shares for $1.4 Million
The Motley Fool • Will Healy
EVP and COO Sells 23,654 Innodata Shares for $1.4 Million

01/06/2026 12:30 PM • Ashok Mishra, EVP and COO of Innodata, sold 23,654 shares worth approximately $1.4 million on December 4, 2025, through an option exercise and immediate sale. This represents a 28% reduction in his direct holdings, leaving him with 60,000 shares. Despite the insider selling, analysts note this is not necessarily bearish as Mishra retained a significant position and the stock has surged from $5 in spring 2024 to over $60, driven by AI-driven data solutions.

SHOP - Mentioned only in context of CEO Kaz Nejatian's previous role as COO, with no direct analysis of the company's performance
INOD - While insider selling could be viewed negatively, the article frames this as a routine position trimming rather than a bearish signal. Mishra retained 60,000 shares, indicating continued confidence. The stock has experienced significant growth from $5 to $60+ driven by AI adoption, and the P/E ratio of ~60 is reasonable for a growth-oriented AI stock. The sale appears to be profit-taking at a favorable valuation rather than a loss of confidence in the company.
#insider selling #stock options #AI-driven solutions #data engineering #digital transformation #executive compensation #liquidity event
Read More
Bronstein, Gewirtz & Grossman LLC Urges StubHub Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges StubHub Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/06/2026 12:00 PM • A class action lawsuit has been filed against StubHub Holdings, Inc. alleging that its September 2025 IPO registration statement was materially false and misleading. The complaint claims the company omitted disclosure of changes in vendor payment timing that significantly impacted free cash flow, and that positive statements about the company's business lacked a reasonable basis. Investors have until January 23, 2026 to request lead plaintiff status.

PLTR - 63% Q3 revenue growth, 52% government revenue increase, profitable with $393.3 million Q3 operating income, consistent sales growth
STUB - The company is accused of making materially false and misleading statements in its IPO registration statement, specifically regarding vendor payment timing changes and their impact on free cash flow. These allegations of securities fraud and disclosure violations represent significant legal and reputational risk to investors.
#class action lawsuit #securities fraud #IPO #registration statement #free cash flow #investor harm #material misstatement
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baidu, Inc. - BIDU
GlobeNewswire Inc. • Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baidu, Inc. - BIDU

01/06/2026 12:00 PM • Law firm Pomerantz LLP is investigating Baidu for potential securities fraud following a Bloomberg report that the Pentagon concluded the Chinese tech company should be added to a list of firms aiding the Chinese military. Baidu's ADR stock fell 1.31% on the news.

BBAI.WS - Q3 sales fell 20%, operating losses doubled, net losses of $288 million, struggling revenue growth, and challenges maintaining government contracts
BIDU - Pentagon designation as aiding Chinese military triggered securities fraud investigation and caused immediate 1.31% stock price decline, raising concerns about regulatory risks and potential delisting or sanctions.
#securities fraud #Pentagon #Chinese military #class action #stock decline
Read More
Bronstein, Gewirtz & Grossman LLC Urges SLM Corporation a/k/a Sallie Mae Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges SLM Corporation a/k/a Sallie Mae Investors to Act: Class Action Filed Alleging Investor Harm

01/06/2026 12:00 PM • A class action lawsuit has been filed against SLM Corporation (Sallie Mae) alleging that the company made materially false and misleading statements regarding its business operations. The complaint claims defendants overstated the effectiveness of loss mitigation programs and concealed a significant increase in early-stage loan delinquencies, artificially inflating stock prices during the July 25 - August 14, 2025 period. Investors have until February 17, 2026 to request lead plaintiff status.

SLM - The company is accused of making materially false and misleading statements about its business operations, specifically concealing significant increases in early-stage delinquencies and overstating the effectiveness of its loss mitigation programs. These allegations of securities fraud and investor harm directly harm shareholder value and company reputation.
#class action lawsuit #securities fraud #false statements #loan delinquencies #investor harm #lead plaintiff deadline
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
GlobeNewswire Inc. • Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

01/06/2026 12:00 PM • Pomerantz LLP is investigating potential securities fraud claims against Ventyx Biosciences following the company's December 2, 2025 announcement that it was delaying topline data release from its Phase 2 recurrent pericarditis trial to Q1 2026. The delay announcement triggered a 15.35% stock price decline, falling from approximately $9.38 to $7.94 per share.

NVDA - Earnings results anticipated this week, with market watching closely
VTYX - The company faces a securities fraud investigation following a significant stock price decline (15.35%) triggered by the announcement of a clinical trial data delay. The delay and subsequent investigation suggest potential investor concerns about misleading guidance or undisclosed material information.
#securities fraud #class action lawsuit #clinical trial delay #stock price decline #Phase 2 study #VTX2735
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Village Farms International, Inc. - VFF
GlobeNewswire Inc. • Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Village Farms International, Inc. - VFF

01/06/2026 12:00 PM • Pomerantz LLP is investigating potential securities fraud claims against Village Farms International following the company's failure to secure a conditional medical license from the Texas Department of Public Safety on December 1, 2025. The announcement triggered a 9.3% stock price decline on December 2, 2025.

PLTR - Advanced 0.73% after partnering with Multiverse to launch NHS staff apprenticeship programs
VFF - The company failed to obtain a conditional medical license from Texas DPS, resulting in a 9.3% stock price drop. Additionally, a law firm is investigating potential securities fraud and unlawful business practices by company officers and/or directors, indicating serious legal and operational challenges.
#securities fraud #class action lawsuit #Village Farms International #Texas medical license #stock price decline #investor investigation
Read More
PRMB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Primo Brands Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
PRMB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Primo Brands Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

01/06/2026 12:00 PM • A class action lawsuit has been filed against Primo Brands Corporation and its officers for alleged securities law violations. The complaint alleges that defendants misrepresented facts about the merger between Primo Water and BlueTriton Brands, making false statements about merger integration progress, growth acceleration, operational efficiencies, and synergies. Investors who purchased stock during the specified periods are encouraged to join the case, with a lead plaintiff deadline of January 12, 2026.

BApA - Slight 0.30% increase after Emirates placed third order for 777X airplanes
PRMB - Company is subject to a class action lawsuit alleging securities fraud, misrepresentation of merger integration progress, and false statements about financial performance and synergies, resulting in investor losses.
#class action lawsuit #securities fraud #merger integration #misrepresentation #investor losses #Primo Water #BlueTriton Brands
Read More
Bronstein, Gewirtz & Grossman LLC Urges Stride, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges Stride, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/06/2026 12:00 PM • A class action lawsuit has been filed against Stride, Inc. alleging securities fraud during the period of October 22, 2024 to October 28, 2025. The complaint claims Stride made misleading statements about its educational products and services while allegedly inflating enrollment numbers with 'ghost students,' violating staffing requirements, ignoring compliance and special education mandates, suppressing whistleblowers, and losing enrollments to preserve profit margins.

BA - Slight 0.30% increase after Emirates placed third order for 777X airplanes
LRN - The company is accused of multiple serious violations including fraudulent enrollment practices, staffing violations, regulatory non-compliance, special education service denials, and whistleblower suppression. These allegations represent significant operational, legal, and reputational risks that would negatively impact investor confidence and shareholder value.
#class action lawsuit #securities fraud #Stride Inc. #investor harm #misleading statements #ghost students #enrollment inflation #compliance violations #whistleblower suppression
Read More
Yellow and Unstoppable Domains Launch .yellow, a Web3 Domain for Identity, Connection and Opportunity
GlobeNewswire Inc. • Na
Yellow and Unstoppable Domains Launch .yellow, a Web3 Domain for Identity, Connection and Opportunity

01/06/2026 12:00 PM • Yellow and Unstoppable Domains announced the launch of .yellow, a Web3-only top-level domain designed to provide individuals, creators, and businesses with self-owned digital identity. The domain includes onchain website hosting, human-readable crypto payments, and decentralized messaging with no renewal fees, combining Yellow's Layer3 protocol infrastructure with Unstoppable Domains' digital identity platform.

DELL - Stock tumbled 4.04% after Morgan Stanley downgraded from 'Overweight' to 'Underweight'
YELLQ - Yellow is expanding its Web3 ecosystem through a strategic partnership to launch .yellow domain, extending its infrastructure into digital identity and demonstrating commitment to mass adoption of Web3 with tangible products and services.
#Web3 domain #digital identity #blockchain #TLD #decentralized applications #crypto payments #Layer3 protocol
Read More
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/06/2026 12:00 PM • A class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) alleging that company executives made false and misleading statements regarding 2026 guidance and overstated the financial impact of strategic risk reduction actions. The lawsuit covers investors who purchased agilon securities between February 26, 2025 and August 4, 2025. The lead plaintiff deadline is March 2, 2026.

GOOGL - Stock rose 5.39% after Berkshire Hathaway unveiled a $4.34 billion stake in the company
AGL - The company is the subject of a securities fraud class action lawsuit alleging reckless issuance of unachievable 2026 guidance and material overstatement of financial benefits from strategic actions, indicating serious corporate governance and disclosure violations.
#class action lawsuit #securities fraud #false guidance #investor harm #agilon health
Read More
Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm

01/06/2026 12:00 PM • A class action lawsuit has been filed against Klarna Group plc alleging that the company made false and misleading statements in its September 2025 IPO registration statement. The complaint claims Klarna materially understated the risk of increased loss reserves and failed to disclose risks related to its buy-now-pay-later loan portfolio. Investors who purchased Klarna securities during the IPO can join the case with a lead plaintiff deadline of February 20, 2026.

KLAR - The company is the subject of a securities fraud class action lawsuit alleging material misstatements and omissions in its IPO registration statement regarding loss reserve risks and BNPL loan portfolio risks, which directly harms investor confidence and shareholder value.
#class action lawsuit #securities fraud #IPO #loss reserves #buy-now-pay-later #BNPL #investor harm #registration statement
Read More
Joby Aviation Preps For Air Taxi Pilot Training and CES 2026
Benzinga • Erica Kollmann
Joby Aviation Preps For Air Taxi Pilot Training and CES 2026

01/06/2026 11:53 AM • Joby Aviation announced significant progress toward commercializing urban air mobility by installing CAE flight simulators at its Marina, California pilot training facility. The company is preparing for commercial launches targeted for late 2026 and plans to double manufacturing capacity by 2027. CEO JoeBen Bevirt will speak at CES 2026 about physical AI and software-defined mobility. Joby stock has climbed over 50% in the past six months.

JOBY - Company is achieving key milestones toward commercialization including flight simulator installation, facility expansion, and planned commercial launches in late 2026. Stock performance has been strong with 50% gains over six months. CEO speaking engagement at CES 2026 demonstrates industry prominence and momentum in the urban air mobility sector.
#air taxi #urban air mobility #pilot training #eVTOL #CAE flight simulators #CES 2026 #commercialization #manufacturing capacity
Read More
Lockheed Martin Lands Pentagon Deal To Triple PAC-3 Missile Output
Benzinga • Lekha Gupta
Lockheed Martin Lands Pentagon Deal To Triple PAC-3 Missile Output

01/06/2026 11:30 AM • Lockheed Martin secured a seven-year framework agreement with the U.S. Department of Defense to significantly increase PAC-3 Missile Segment Enhancement (MSE) interceptor production from approximately 600 to 2,000 units annually. The deal provides long-term demand visibility, supports production capacity expansion, and creates thousands of American jobs. The stock rose 3.66% to $530.28, reaching a new 52-week high.

LMT - The company secured a major seven-year Pentagon contract to triple PAC-3 missile production, providing long-term revenue visibility and demand certainty. The deal supports capacity expansion, job creation, and recent stock performance shows a 3.66% gain to a new 52-week high, reflecting strong market confidence in the contract win.
#PAC-3 Missile #Pentagon contract #defense production #military procurement #production capacity #Foreign Military Sales
Read More
Thermoplastic Composites Market Size is Poised to Reach USD 54.03 Billion by 2033 Owing to the Increasing Use of Lightweight Materials in Automotive Industry Globally | SNS Insider
GlobeNewswire Inc. • Sns Insider
Thermoplastic Composites Market Size is Poised to Reach USD 54.03 Billion by 2033 Owing to the Increasing Use of Lightweight Materials in Automotive Industry Globally | SNS Insider

01/06/2026 11:00 AM • The global thermoplastic composites market is estimated at USD 29.60 billion in 2025 and is projected to reach USD 54.03 billion by 2033, growing at a CAGR of 7.83%. Growth is driven by increasing demand for lightweight, recyclable materials in the automotive and aerospace industries, with Asia Pacific leading the market and North America showing the fastest growth.

FHTX - Mentioned as a previous company where Kristian Humer served as CFO, with no specific context provided
CE - Celanese expanded its strategic partnership with distributor Biesterfeld in January 2025 to include long-fiber reinforced thermoplastic products, enhancing market access and strengthening its engineered polymers portfolio during a period of strong market growth.
#thermoplastic composites #lightweight materials #automotive industry #aerospace and defense #recyclable materials #polypropylene #carbon fiber #market growth
Read More
Free Live Sports Expands Global Footprint, Signing 7 New Distribution Deals to Bring Its Unparalleled Sports Content to Over 75 Million Households
GlobeNewswire Inc. • Sports Studio Inc.
Free Live Sports Expands Global Footprint, Signing 7 New Distribution Deals to Bring Its Unparalleled Sports Content to Over 75 Million Households

01/06/2026 11:00 AM • Free Live Sports announced seven new global distribution deals expanding its reach to over 75 million households worldwide. The agreements include partnerships with VIDAA, Rakuten TV, Titan OS, Whale TV, Anoki, Swift TV, and 3SS for automotive entertainment, significantly strengthening FLS's presence across Connected TV platforms, smart TVs, and in-vehicle systems across North America, Europe, Latin America, and Asia.

RKUNY - Partnership with FLS adds premium sports content to its platform, enhancing viewer value proposition and competitive positioning in the streaming market.
#streaming platform #sports content #distribution deals #Connected TV #FAST channels #global expansion #smart TV platforms #in-vehicle entertainment
Read More
NXP and GE HealthCare Accelerate AI Innovation in Acute Care
GlobeNewswire Inc. • Na
NXP and GE HealthCare Accelerate AI Innovation in Acute Care

01/06/2026 11:00 AM • NXP Semiconductors and GE HealthCare announced a collaboration to develop edge AI concepts for anesthesiology and neonatal care. The partnership will showcase two advanced concepts at CES 2026: a voice-command system for anesthesia equipment and intelligent monitoring technology for neonatal intensive care units. Both solutions leverage NXP's edge processing capabilities and neural processing units with emphasis on security, privacy, and low-latency performance.

HEINY - Routine financial reporting of share buyback program with no significant positive or negative indicators, representing standard corporate financial management
NXPI - NXP is expanding its edge AI portfolio into high-value healthcare markets through a strategic partnership with a leading medical technology company. The collaboration demonstrates NXP's technological capabilities in secure, high-performance edge processing and positions the company in the growing healthcare AI sector.
#edge AI #medical technology #anesthesiology #neonatal care #neural processing units #healthcare innovation #secure computing #CES 2026
Read More
Truepic Welcomes Kerry Whorton Cooper to its Board of Advisors
GlobeNewswire Inc. • Not Specified
Truepic Welcomes Kerry Whorton Cooper to its Board of Advisors

01/06/2026 11:00 AM • truepic announced the addition of Kerry Whorton Cooper to its Board of Advisors. Cooper brings over two decades of executive leadership experience and currently serves as board chair at PG&E Corporation and Mozilla Corporation, and as lead independent director at Upstart. She will support truepic's efforts to help enterprises combat AI-driven fraud and visual risk in retail and manufacturing sectors.

PCG - PG&E is mentioned only as the current board chair position of the newly appointed advisor. There is no direct news or impact on PG&E's operations or business.
#Visual Risk Intelligence #board appointment #AI fraud prevention #retail fraud #image authentication #executive leadership
Read More